Deletions from the derivative chromosome 9, der(9), of the translocation, t(9;22)(q34;q11), at the site of the ABL/BCR fusion gene, have been demonstrated by fluorescence in situ hybridisation (FISH), in both Philadelphia chromosome (Ph)-positive chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL). In CML they occur in 10-15% of cases and appear to indicate a worse prognosis, whereas in ALL, the situation is unclear. This study presents the findings of dual fusion FISH used to detect such deletions in a series of 27 BCR/ ABL-positive childhood ALL patients. Metaphase FISH was essential for the accurate interpretation of interphase FISH signal patterns. Three cases (11%) had a single fusion signal, resulting from deletions of the der(9). Three other patients with variant translocations and one with an insertion, also had a single fusion, but with no evidence of deletions. Gain of a fusion in approximately one-third of patients indicated a second Ph, which appears to be a diagnostic marker of Phpositive ALL. This study shows that the incidence of deletions from the der(9) in childhood ALL is at least as high as that reported for CML.
Introduction
Fluorescence in situ hybridisation (FISH) is increasingly being used to identify significant gene rearrangements in acute leukaemia. A range of commercial probes are now available, providing rapid and accurate detection systems. These include a number of probe systems, which have been developed for the detection of the BCR/ABL fusion gene. This gene, usually located on the Philadelphia chromosome (Ph), arises from a reciprocal translocation between chromosomes 9 and 22 at breakpoints q34 and q11, respectively, t(9;22)(q34;q11), and results in the fusion of the 3 0 segment of the ABL gene to the 5 0 segment of BCR. The rearrangement, the hallmark of chronic myeloid leukaemia (CML), also occurs in 11-30% of adults 1 and 3-5% of children with acute lymphoblastic leukaemia (ALL). 2, 3 In ALL it is associated with a poor prognosis in both age groups. 4 Expression of the fusion gene in ALL, results in two types of chimaeric mRNA, dependent upon the location of the breakpoint within the breakpoint cluster region (bcr) of the BCR gene. In a third of patients with ALL and the majority of those with CML the breakpoint occurs within a 5.8 kb region spanning BCR exons 12-16 (exons b1-b5), known as the major bcr (M-bcr). The translocation involving this breakpoint results in the production of a p210 BCR-ABL protein.
In the remaining twothirds of ALL patients and rarely in CML, the breakpoint arises further upstream, between exons e2' and e2, known as the minor bcr (m-bcr). The translocation involving this breakpoint produces a p190 BCRÀABL protein. 5 FISH has shown that deletions involving the reciprocal ABL/ BCR fusion gene occur at the site of the translocation breakpoint on the derivative chromosome 9, der(9), of the t(9;22) in both CML and ALL. In CML they were observed by using a dual colour dual fusion approach. 6 This technique allows for the detection and (where metaphases are present) location of both the BCR/ABL and ABL/BCR fusion genes. 7 In cells with a deletion, one or both of the signals corresponding to ABL/BCR are absent from the der (9) . These findings were correlated with molecular studies indicating loss of the ABL/BCR fusion transcript in a number of patients. 6 However, not all patients who lack expression of the ABL/BCR fusion gene at the molecular level have a visible deletion by FISH. 8 FISH studies showed that 10-15% of patients with CML had a deletion involving ABL/BCR, and that the incidence was higher among those patients with variant Ph translocations. 6 The most significant clinical finding was that, in CML, the deletions were associated with a worse prognosis. [9] [10] [11] [12] More recent investigations have shown that these deletions also occur in adult ALL, although no association with outcome has yet been established. 13, 14 In the study presented here, a series of 27 BCR/ABL positive, childhood ALL patients were investigated using dual colour dual fusion FISH, with a commercially available probe, to determine the incidence of ABL/BCR deletions. Comparison of FISH signal patterns, at both interphase and metaphase with the G-banded karyotypes, revealed unexpected findings.
Materials and methods

Patients
Patients with a confirmed diagnosis of Ph-positive ALL entered to one of the National Cancer Research Institute (NCRI) ALL treatment trials, ALL97 or ALL2003, for children aged 1-18 years inclusive, with available material, were included in this study. They had been previously identified as Ph-positive by conventional cytogenetics and/or interphase FISH. Demographic, clinical and survival data were provided by the Clinical Trial Service Unit (CTSU), Oxford.
Cytogenetics
Conventional cytogenetic analysis was carried out on diagnostic bone marrow and/or peripheral blood samples by the UK regional cytogenetics centres. Members of these laboratories form the UK Cancer Cytogenetics Group. G-banded slides were reviewed by the Leukaemia Research Fund UKCCG Karyotype Database in Acute Leukaemia (Database) 15 as part of their routine review of all cases entered to ALL97. Slides from case 7092, an ALL2003 patient, were not available for review, thus an incomplete karyotype (inc), based on metaphase FISH analysis only, was given. Karyotypes were described according to the International System of Human Cytogenetic Nomenclature (ISCN, 1995 . In all three probes, ABL sequences were labelled with Spectrum Orange, providing a red signal, and BCR sequences were labelled with Spectrum Green, providing a green signal. Although the size and extent of the sequences included in the probes varied, as indicated in Figure 1 , all normal cells showed two red and two green signals (2R2G) in interphase. The designs of the SF and the ES probes allow detection of breakpoints involving the m-bcr of the BCR gene as well as the BCR/ABL fusion. 17, 18 The interphase FISH patterns expected with each probe are shown in Table 1 . For those cases with standard and nonstandard signal patterns observed in interphase, the number and relative size of the signals were confirmed, where possible, on representative metaphase cells from the same samples. This allowed the location of the individual signals to be determined in relation to relevant chromosomal abnormalities.
In two patients (4582, 4239), the Chromoprobe Multiprobe-It system (Multiprobe-I) (Cytocell, UK), which comprises centromeric probes specific for each chromosome pair, was used to enumerate individual chromosomes. 19 A total of 100 interphase nuclei were scored for each centromeric probe.
Whole chromosome paints (wcp) (STARnFISH, Cambio, UK) and Multiplex-FISH (M-FISH), using the SpectraVysion 24 colour chromosome painting kit (Vysis, UK), were applied to metaphases from patient 5643, in order to clarify the G-banded karyotype. Subtelomeric probes, specific for the short and long arms of chromosome 9 (9p and 9q) (QBiogene, UK), were sequentially hybridised onto the same metaphases. Detailed investigation of the BCR/ABL rearrangement in this patient was carried out by FISH with specific overlapping PAC probes covering the ABL gene. PAC probe dJ1132H12 maps 5 0 to 3 0 and includes ABL intron 1 while dJ835J22 maps 5 0 to 3 0 and includes ABL exon 11. 20 The probes were directly labelled with Spectrum Red and Spectrum Green, respectively, by Nick translation (Vysis, UK) and hybridised to slides using a modified method for noncommercial probes, as previously described. 21 
Results
Among 2096 patients entered to ALL97 and 179 with complete data, entered to ALL2003 by 30 June 2004, 49 patients were Phpositive. In total, 27 of these children (18 males and nine females), with fixed cell suspensions available for further investigation, were included in this study. The median age was 6 years (range 1-15 years), the mean white blood cell count was 128 Â 10 9 /l, and the immunophenotype was pre-B or common ALL.
Cytogenetics
Cytogenetic data and FISH results from at least two probes were available for the majority of patients. The karyotypes and FISH signal patterns from the different probes are shown in Table 2 . Patients are ordered according to their interphase FISH signal pattern with the DF probe. The translocation t(9;22)(q34;q11) appeared as the sole chromosomal abnormality in four patients (3192, 3537, 4331, 4622). Complex-variant Ph translocations were observed in three patients (4018, 4239, 4844). There was no cytogenetic evidence of a Ph translocation in one patient (5643) with a pseudodiploid karyotype. Additional chromosomal 
Breakpoint in m-bcr: detection by FISH
A total of 25 patients were tested with the SF and/or ES probes, of which 15 showed a FISH signal pattern consistent with a breakpoint within m-bcr of 1R2G1F or 1R2G2F with the SF probe (13 patients), or 1R1G2F with the ES probe (two patients) ( Table 2 ). Since the signal from the 3 0 BCR fragment with both probes is always smaller than the normal BCR signal, nondetection of this small signal may sometimes be due to limited resolution and should not be interpreted as representative of an M-bcr breakpoint without supporting evidence from additional molecular analyses. Thus 10 patients without a signal pattern indicative of an m-bcr breakpoint and two others not tested with either probe were reported as not known (NK).
DF FISH
The presence of the BCR/ABL fusion gene was confirmed by FISH using the DF probe in all 27 patients. A variety of interphase FISH signal patterns were observed as shown in Table 2 . A single fusion signal, rather than the standard two, was detected in nine patients. Loss of a fusion signal (1R1G1F) and its component parts were seen in two patients, but only at interphase (Figure 2a ). One had a normal karyotype by Gbanding (3005) and the other a failed cytogenetic result (4786). In three patients (4412, 4483, 7092), the single fusion signal resulted from deletion of a component of the ABL/BCR fusion. Loss of a red signal at interphase in patient 4483 was confirmed in metaphase (Figure 2b ) to correspond to deletion of the chromosomal region including the 5 0 ABL sequences from the der(9). Loss of a green signal was seen from each of the two interphase populations that patients 7092 and 4412 had in common (2R1G1F, 2R1G2F). The loss of the 3 0 BCR signal from the der(9) in patient 7092, was confirmed on metaphases (Figure 2c and d) . In this patient the red signal on the der(9) chromosome was consistently smaller and was not clearly visible in all interphase cells, indicating that the deleted region might include some sequences from the 5 0 part of ABL in addition to 3 0 BCR. The SF probe confirmed in patient 4412 that there was an intact fusion on the Ph, indicating the presence of 5 0 BCR sequences, in spite of there being no suitable metaphases for analysis with the DF probe. The additional fusion signal, seen in interphase in some cells of both patients, proved on metaphases to be a second Ph. Without metaphases in these two cases to confirm that the common 2R1G2F interphase signal pattern indicated the loss of 3 0 BCR, one might have been misled into underestimating the incidence of deletions in ALL, or misinterpreting that the deletion arose as a secondary event to the translocation.
A single green and a single fusion signal (2R1G1F) were observed in the interphase cells from patient 5643 (Figure 2e ). There was no evidence of a Ph in the abnormal metaphases of this patient by conventional cytogenetics. Sequential metaphase FISH with the DF probe and M-FISH, showed the fusion signal to be located on an apparently normal chromosome 22 and the ABL signals to the 9q34 bands of two copies of chromosome 9, one of normal appearance, the other with an interstitial deletion in the short arm (Figure 2e ). This indicated that BCR/ABL fusion had resulted from a submicroscopic insertion of chromosome 9 material into chromosome 22. Metaphase FISH, with individual PAC probes covering the ABL gene, indicated that there was no deletion from the der(9) since both 5 0 and 3 0 sequences of the gene were present on both copies of chromosome 9, with 3 0 sequences also on the der (22) (Figure 2f ). The insertion event was confirmed by further sequential hybridisation of 9p and 9q subtelomeric probes, which showed that the telomeric regions of both copies of chromosome 9 were intact (Figure 2g ). In this case, although both the SF and DF probes had identical nonstandard interphase patterns, only metaphase FISH was able to identify the location of the fusion.
The single fusion signal in the 2R2G1F pattern observed at interphase in three patients (4018, 4239, 4844) was due to Table 1 Signal patterns from FISH probe systems detecting BCR/ABL rearrangements Metaphase FISH proved that the red ABL signal of the second fusion was retained on the der(9), while the green BCR one was relocated to the third chromosome involved in the translocation (chromosome 10, patient 4844, chromosome 12, patient 4018). No metaphases were available for FISH studies in patient 4239. Interphase FISH did however reveal a second population with two fusions (2R2G2F) in this patient, while Multiprobe-1 showed a hidden hyperdiploid population, including a third copy of chromosome 22 centromere. The second interphase fusion was thus consistent with being an extra copy of the Ph. Although conventional cytogenetics identified the variant translocations, only metaphase FISH demonstrated that the ABL and BCR components of the der(9) fusion had remained intact. Patient 5673 showed a 2R1G2F pattern indicating an additional copy of the ABL signal. This was consistent with the presence of an isochromosome 9, i(9)(q10), seen by cytogenetics in which the duplication of the long arm of chromosome 9 accounted for the extra ABL signal. A second population observed in this patient with the standard 1R1G2F pattern, indicating a single copy of ABL, may represent a nondividing population without i(9)(q10), suggesting that this abnormality may be a secondary chromosomal change. Metaphase FISH was needed in order to distinguish this case from the two deletion cases with the same 2R1G2F pattern, which had arisen by a different mechanism, namely deletion of the green part of the der(9) fusion with acquisition of a second copy of the Ph, as described above.
Seven patients showed a 1R1G3F pattern, associated with the gain of a fusion signal in all (4684, 2896, 3715, 4102, 4914) or in some of the cells (4289, 4582). This correlated with an additional fusion signal seen with either the SF or ES probes in all cases except 4684. Metaphase FISH and G-banded analysis in six of these patients confirmed the presence of an additional Multiprobe-I confirmed +X,+11,+18,+21,+21,+22.
c Multiprobe-I confirmed +X,+Y,+2,+4,+6,+8,+10,+14,+17,+18,+20,+21,+21,+22. Normal (2R2G) FISH signal patterns and normal populations by cytogenetics have not been included. 0 BCR signal from der(9) chromosome (arrowed) (patient 7092), in (c) there is an additional copy of the Ph. (e) BCR/ABL fusion (arrowed) on an apparently normal chromosome 22, together with two copies of ABL (red) and a single copy of BCR (green) on chromosomes 9 and 22 followed by sequential M-FISH (patient 5643). (f) PAC probes, dJ1132H12 (red) and dJ835J22 (green), hybridised to metaphases showing the presence of both PACs on the two copies of chromosome 9 and dJ835J22 on the ins(22) (arrowed) (patient 5643) (g) partial karyotype of the two copies of chromosome 9, hybridised with p (green) and q (red ) subtelomeric probes (patient 5643). extra chromosome 22 centromere, implied the presence of a second Ph.
The remaining 10 patients showed the standard pattern of 1R1G2F, indicating the presence of both the BCR/ABL and ABL/ BCR fusions. These results were consistent with the cytogenetic findings of a balanced t(9;22)(q34;q11), apart from one case (3864) with a normal karyotype, in which no abnormal metaphases were seen either by G-banded analysis or FISH, indicating that the abnormal clone was restricted to the nondividing population.
Discussion
This study records the detailed interphase FISH patterns and chromosomal locations of probes to the BCR and ABL genes, in a series of children with Ph-positive ALL. We identified a significant number of cases with deletions from the der(9), as well as variant translocations without apparent deletions from either chromosome 9 or 22. We recorded the first insertion event in a child with ALL using FISH, while the extra copy of the Ph seen in several cases, may prove to be a feature of diagnosis in this disease.
A third of the patients showed a single fusion with the DF probe rather than the expected two, in all, or in a majority of cells. In three patients, the fusion on the der (22) together with loss of either the red or the green signal from the der(9), indicated a deletion of sequences including 5 0 ABL or 3 0 BCR from the breakpoint region of the der(9). The variable extent of the deletions exhibited in this study and other small series 9, 11, 13, 14 indicate that they are likely to be as molecularly heterogeneous as those reported in CML. 6, 13, 20, 22 In agreement with Huntly et al 9 for CML, we found the deletions to be present in all cells of our ALL patients. Thus they must have occurred at the same time as the original translocation event, and not as the result of clonal evolution.
Three other patients with a single fusion signal had variant translocations in which the fusion signal from the der(9) was split between this chromosome and the third partner, with no evidence of accompanying deletions. These findings, albeit in only a small number of patients, contrast with the situation in CML, in which a higher incidence of deletions was demonstrated in those with variant Ph translocations. 23 One patient among the series with a single fusion signal showed, from a combination of FISH techniques, that the BCR/ ABL fusion had arisen from insertion of part of the ABL gene into chromosome 22, with no accompanying deletion of the corresponding sequences from the der (9) . A number of cryptic insertions of either BCR into ABL at 9q34, as reviewed by Primo et al, 24 or rarely ABL into BCR at 22q11, 25 have been reported in CML, with the insertions confirmed by dual fusion FISH. 7, 18, [25] [26] [27] [28] An insertion is sometimes seen as the end point of a series of events. Thus, in our case, either the der(9) chromosome which provided ABL sequences to chromosome 22 could have been lost, with subsequent duplication of the normal copy of chromosome 9, or else there could have been a partial duplication of ABL sequences on the der(9), which preceded their insertion into chromosome 22. The deletion of the short arm of one of the copies of chromosome 9 in this patient is a known, secondary feature of childhood Ph-positive ALL associated with a worse prognosis. 29 The frequency of deletions from the der(9) in CML has been estimated to be 10-15% from a number of studies. 6, [9] [10] [11] [12] 30 The incidence reported for ALL is more variable. In our study, the figure of 11% for confirmed deletions is similar to that reported for adult ALL by Specchia et al 13 and Kolomietz et al. 11 A lower incidence of 1.5% was reported by Reid et al 14 in their predominantly adult series, while no cases were detected in the series investigated by Lee et al. 31 This variation may be a consequence of the small numbers of patients studied, or of a bias in selection. Alternatively, as suggested from our study, there is a possibility that some deletions may be masked by a predominant secondary population with two fusion signals. It has been proposed that der(9) deletions are more commonly associated with M-bcr breakpoints. 13 Therefore, the lower incidence reported by Reid et al, 14 may reflect the smaller number of patients in their series with M-bcr rearrangements. Our study is incapable of providing support, since the assignment of breakpoints within BCR was made by FISH and deletion of ABL in association with an m-bcr breakpoint was only confirmed in a single case.
An additional fusion signal at interphase correlated with a second copy of the Ph. There was evidence of a second copy of the Ph in a third of the patients in this study, which compares with the results of a previous series of similar size. 18 In contrast, the presence of two Ph at diagnosis of CML was much rarer. This implies that the presence of an additional Ph may be a diagnostic marker of Ph-positive ALL.
In CML, der(9) deletions have been associated with a worse prognosis. [9] [10] [11] [12] 23 The poor outcome has been linked to patients with a visible deletion by FISH. Cases of Ph-positive CML have been reported, which lack expression of the ABL/BCR transcript but have no visible deletions. 8, 27 Such submicroscopic deletions, below the level of detection by FISH, have been identified in a small series of patients whose prognosis was poor. 9 A candidate tumour suppressor gene, PRDM12, was identified in these cases 32 and subsequently shown to be deleted in a case of Ph-positive CML with a variant translocation. 33 No association with survival has yet been established for deletions of der(9) in ALL. The identification of tumour suppressor genes in CML and the determination of their potential role in prognosis may also have implications for ALL. Ph-positive ALL has an extremely poor outcome, which may be attributable to the loss of unidentified tumour suppressor genes. Although we can draw no conclusions about prognosis owing to the short follow-up time, it is of interest that four of our patients with deletions did not show a good response, based on the percentage of blasts at day eight of treatment (unpublished observations).
Parallel cytogenetic, interphase and metaphase FISH studies with probes specific for the BCR and ABL genes on a series of children with Ph-positive ALL provided detailed results, which could not have been achieved from any of the techniques independently. This study demonstrates the importance of supplementing conventional cytogenetics with FISH for the correct identification of BCR/ABL positivity in children with ALL. It confirms that conventional cytogenetics provides useful supporting evidence in cases with a visible chromosomal abnormality and, as emphasised by other workers, 9, 12, 18, 24, 28, 34 shows that metaphase FISH should always be employed in interpreting interphase FISH results. Thus it could not be assumed that, in our two cases with no available metaphases or additional, supporting interphase FISH, the complete loss of both components of the second fusion was due to deletions from the der (9) . Although a strong association has been established between loss of ABL/BCR signals and deletions from the der(9), we have clearly demonstrated that alternative explanations exist. With the introduction of new treatments for Ph-positive patients, this approach will have particular relevance, should specific FISH patterns, particularly deletions, be found to have prognostic implications.
